Whole Blood Transcriptome Analysis in Congenital Anemia Patients

Area of Science:

• Hematology
• Genomics
• Molecular Biology

Background:

• Congenital anemias encompass diverse red blood cell disorders, including hemoglobinopathies and defects in erythropoiesis.
• These conditions share a common origin in erythropoiesis dysfunction but exhibit significant phenotypic heterogeneity.
• Previous research has not comprehensively compared gene expression across multiple congenital anemias.

Purpose of the Study:

• To compare transcriptomic profiles of sickle cell disease, thalassemia, and congenital sideroblastic anemia (CSA).
• To identify common and distinct gene expression patterns in these congenital anemias.
• To discover genes with potential clinical relevance for congenital anemias.

Main Methods:

• Quant 3' mRNA-Sequencing was employed to analyze gene expression.
• Transcriptomic profiles were compared between patients with sickle cell disease, thalassemia, and SLC25A38 CSA, and healthy controls.
• Differential gene expression analysis was performed.

Main Results:

• All studied congenital anemias showed differentiated gene expression compared to healthy controls.
• Genes involved in metabolic processes, membrane function, and erythropoiesis were upregulated in sickle cell disease and thalassemia.
• The SLC25A38 CSA patient exhibited a unique gene expression pattern distinct from other congenital anemias.

Conclusions:

• Congenital anemias display unique transcriptomic signatures.
• Shared gene expression changes in metabolic and erythropoiesis pathways are observed in hemoglobinopathies.
• SLC25A38 CSA presents a distinct molecular profile, highlighting the diversity within congenital anemias.